
Illustrative image. Catalogue strength: 10 mg; image label may differ.
Retatrutide
A synthetic peptide reference material studied in the published literature as a multi-receptor incretin agonist.
- Material
- Retatrutide
- Form
- Lyophilized powder
- Vial quantity
- 10 mg · 1 vial
- Batch number
- LAN-RETA-2609-01
- Testing status
- Report published
- Storage
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Supplied for laboratory research use only. Not for human or veterinary use.
Latest Test Results
Batch: LAN-RETA-2609-01
- Identity
- Retatrutide identified by HPLC-MS/MS
- Quantity
- 9.85 mg net peptide content (10.00 mg label claim; 98.5% fill accuracy)
- Purity
- 99.6% chromatographic purity
- Additional testing
- Endotoxin: below 0.11 EU/mL (kit limit: 1 EU/mL); kinetic chromogenic LAL/TAL, USP <85>.
- Independent laboratory
- Side-Chain Analytics Inc. / Peptide Test Canada
- Testing date
- September 26, 2026
Tested sample: RET-619; endotoxin sample: ENDO-RET-619. Reports: COA-2026-SC-02740 and COA-2026-SC-02740-EN. Results apply only to the samples received and tested, not other vials or an entire lot or batch. These reports do not establish sterility, safety, efficacy, regulatory compliance, or suitability for human or veterinary use.
Batch archive
- LAN-RETA-2609-01September 26, 2026View record →
- LAN-RETA-2608-01—View record →
Material Overview
Retatrutide (research designation LY3437943) is a synthetic peptide investigated in published research as an agonist at GIP, GLP-1 and glucagon receptors. Supplied strictly as a reference material for in-vitro laboratory research.
Research Context
Retatrutide has been described in peer-reviewed literature investigating triple incretin receptor pharmacology. Published clinical research is conducted under regulated trial conditions and is unrelated to the supply of reference material.
Storage & Handling
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Molecular Information
- Peptide sequence
- Proprietary synthetic sequence (see supplier documentation)
- Molecular formula
- C221H342N46O68
- Molecular weight
- 4731.3 g/mol
- CAS number
- 2381089-83-2
- Synonyms
- LY3437943
- Research classification
- Single peptide reference material
Common questions about Retatrutide
- What purity is Retatrutide tested to?
- Our specification is Reported per batch. Each lot's sample is sent to an independent third-party laboratory, and published reports apply only to the sample tested.
- How should Retatrutide be stored?
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
- What strength and form is supplied?
- 10 mg per vial, supplied as lyophilized powder.
- Where does Retatrutide ship from?
- Orders are processed and dispatched within Canada. Shipping is $22 CAD on orders under $300 and free at $300 or more.
- Is Retatrutide for human use?
- No. It is sold strictly for laboratory research use only and is not for human or veterinary consumption.
